Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote
WEBFind the latest Hims & Hers Health, Inc. (HIMS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: …
WEB2 days ago · In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $18.95, with a -1.86% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0. ...
Hims & Hers Health, Inc. (HIMS) Latest Stock News & Headlines …
WEBGet the latest Hims & Hers Health, Inc. (HIMS) stock news and headlines to help you in your trading and investing decisions.
Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward
WEB1 day ago · With no debt and over $230 million in cash, Hims & Hers is financially robust and profitable, projecting $220 million EBITDA and $170 million free cash flow in 2025. Anticipating a 35% CAGR in ...
Hims & Hers Stock Pops After Massive Acquisition
WEBSep 13, 2024 · Shares of healthcare company Hims & Hers Health (HIMS 0.34%) jumped as much as 23.9% this week after news of closing a large acquisition. According to data provided by S&P Global Market ...
Hims & Hers weight loss adds compounded GLP-1 injections
WEBMay 20, 2024 · Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections. The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced...
Hims & Hers Newsroom
WEBHims & Hers Launches Latest Compounded 2-in-1 Medication: Sex Rx + Climax Control. April 17, 2024.
Hims & Hers Is Now Selling Semaglutide: Here's What You Should …
WEBMay 22, 2024 · Telehealth prescription company Hims & Hers has a new semaglutide initiative. The program will offer compounded semaglutide to customers starting from $199 a month. The company also plans to sell branded Wegovy and Ozempic when it is available.
Hims & Hers Health Surges 30% After Earnings. Here Is Why the …
WEBMar 3, 2024 · Shares of direct-to-consumer telehealth business Hims & Hers Health (HIMS 0.86%) are up 30% since the company reported its Q4 earnings. The little-known $2 billion company is grabbing...
News Details - Hims
WEBJuly 31, 2023. One in four U.S. men die of heart disease. Hims aims to expand access to preventive care with new dual-action capabilities that support sexual health and the heart together, signaling the company’s next frontier of personalized health and wellness.